{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:58:27Z","timestamp":1793854707488,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xphs.2025.103974","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:02:58Z","timestamp":1756191778000},"page":"103974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Co-encapsulated with shikonin\/doxorubicin pH-sensitive liposomes: Preparation, characterization and its synergistic effect in drug-resistant breast cancer cells"],"prefix":"10.1016","volume":"114","author":[{"given":"Huilin","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinliang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianchun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103974_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"10.1016\/j.xphs.2025.103974_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.colsurfb.2014.11.005","article-title":"Paclitaxel\/epigallocatechin gallate coloadedliposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells","volume":"125","author":"Ramadass","year":"2015","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"14","key":"10.1016\/j.xphs.2025.103974_bib0003","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.3390\/molecules27144632","article-title":"Maleimide-functionalized liposomes: prolonged retention and enhanced efficacy of doxorubicin in breast cancer with low systemic toxicity","volume":"27","author":"Tang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2025.103974_bib0004","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-016-3781-4","article-title":"Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up","volume":"156","author":"Murtagh","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10837450.2020.1832116","article-title":"Mitochondrial targeted doxorubicin derivatives delivered by Ros-responsive nanocarriers to breast tumor for overcoming of multidrug resistance","volume":"26","author":"Zhong","year":"2021","journal-title":"Pharm Dev Technol"},{"issue":"10","key":"10.1016\/j.xphs.2025.103974_bib0006","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/md17100581","article-title":"Glycol chitosan-docosahexaenoic acid liposomes for drug delivery: synergistic effect of doxorubicin-rapamycin in drug-resistant breast cancer","volume":"17","author":"Kim","year":"2019","journal-title":"Mar Drugs"},{"issue":"596","key":"10.1016\/j.xphs.2025.103974_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","article-title":"Mechanisms of multidrug resistance in cancer","volume":"596","author":"Gillet","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.xphs.2025.103974_bib0008","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.xphs.2025.103974_bib0009","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/molecules25071748","article-title":"Dual P-glycoprotein and CA XII inhibitors: a new strategy to reverse the P-gp mediated multidrug resistance (MDR) in cancer cells","volume":"25","author":"Teodori","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.xphs.2025.103974_bib0010","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/pharmaceutics14061128","article-title":"pH-sensitive liposomes for enhanced cellular uptake and cytotoxicity of daunorubicin inmelanoma (B16-BL6) Cell Lines","volume":"14","author":"Alrbyawi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"127","key":"10.1016\/j.xphs.2025.103974_bib0011","first-page":"286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xphs.2025.103974_bib0012","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/10837450.2019.1599914","article-title":"Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate a for doxorubicin delivery: preparation, characterization and evaluation","volume":"24","author":"Wang","year":"2019","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"10.1016\/j.xphs.2025.103974_bib0013","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3390\/polym13132047","article-title":"In vitro interaction of doxorubicin-loaded silk sericin nanocarriers with MCF-7 breast cancer cells leads to DNA damage","volume":"13","author":"Radu","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.xphs.2025.103974_bib0014","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2147\/DDDT.S129008","article-title":"Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach","volume":"11","author":"Tefas","year":"2017","journal-title":"Drug Des Dev Ther."},{"issue":"5","key":"10.1016\/j.xphs.2025.103974_bib0015","first-page":"2105","article-title":"Combination treatment using pyruvate kinase M2 inhibitors for the sensitization of high density triple-negative breast cancer cells","volume":"36","author":"Lee","year":"2022","journal-title":"InVivo"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0016","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7150\/ijbs.36955","article-title":"Shikonin induces colorectal carcinoma cells apoptosis and autophagy by targeting galectin-1\/JNK signaling axis","volume":"16","author":"Zhang","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0017","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203834","article-title":"Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis","volume":"41","author":"Lee","year":"2021","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0018","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1038\/s41598-018-21710-5","article-title":"Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells","volume":"8","author":"Mirzaei","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2025.103974_bib0019","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/pharmaceutics11040178","article-title":"Short and long-term effects of the exposure of breast cancer cell lines to different ratios of free or co-encapsulated liposomal paclitaxel and doxorubicin","volume":"11","author":"Franco","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103974_bib0020","doi-asserted-by":"crossref","first-page":"e1450","DOI":"10.1002\/wnan.1450","article-title":"Stimuli-responsive liposomes for drug delivery","volume":"9","author":"Lee","year":"2017","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnology"},{"key":"10.1016\/j.xphs.2025.103974_bib0021","first-page":"76","article-title":"Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy","volume":"9","author":"Shivani","year":"2012","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0022","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.xphs.2025.103974_bib0023","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/pharmaceutics15020369","article-title":"Co-encapsulation of simvastatin and doxorubicin into pH-sensitive liposomes enhances antitumoral activity in breast cancer cell lines","volume":"15","author":"Duarte","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2025.103974_bib0024","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2147\/IJN.S303874","article-title":"A dual pH-responsive DOX-encapsulated liposome combined with glucose administration enhanced therapeutic efficacy of chemotherapy for cancer","volume":"16","author":"Zhai","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2025.103974_bib0025","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.2147\/IJN.S109966","article-title":"Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis","volume":"11","author":"Ferreira","year":"2016","journal-title":"Int J Nanomed"},{"issue":"8","key":"10.1016\/j.xphs.2025.103974_bib0026","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"5","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.xphs.2025.103974_bib0027","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/cam4.1993","article-title":"Resveratrol promotes sensitization to doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1\/beta-catenin signaling pathway in breast cancer","volume":"8","author":"Jin","year":"2019","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.xphs.2025.103974_bib0028","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/03639045.2020.1742145","article-title":"Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis","volume":"46","author":"Jing","year":"2020","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2025.103974_bib0029","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/molecules27010090","article-title":"Co-inhibition of P-gp and Hsp90 by an isatin-derived compound contributes to the increase of the chemosensitivity of MCF7\/ADR-resistant cells to doxorubicin","volume":"27","author":"Abdalla","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2025.103974_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.623760","article-title":"Triggered drug release from liposomes: exploiting the outer and inner tumor environment","volume":"11","author":"Franco","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.xphs.2025.103974_bib0031","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-5793(92)80947-F","article-title":"Gelation of liposome interior A novel method for drug encapsulation","volume":"312","author":"Lasic","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.xphs.2025.103974_bib0032","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijpharm.2018.07.009","article-title":"Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes","volume":"548","author":"Kanamala","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103974_bib0033","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/10826076.2015.1032418","article-title":"Development of a method to evaluate the release profile of tamoxifen from pegylated hybrid micelles","volume":"38","author":"de Souza","year":"2015","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"10.1016\/j.xphs.2025.103974_bib0034","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1208\/s12249-022-02349-y","article-title":"Fusion of tumor-derived exosomes with long-circulating and pH-sensitive liposomes loaded with doxorubicin for the treatment of breast cancer","volume":"23","author":"Gomes","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/10837450.2020.1835957","article-title":"Novel biomimetic nanostructured lipid carriers for cancer therapy: preparation, characterization, and in vitro\/in vivo evaluation","volume":"26","author":"Zhou","year":"2021","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2025.103974_bib0036","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11307-016-0964-7","article-title":"pH-sensitive, long-circulating liposomes as an alternative tool to deliver doxorubicin into tumors: a feasibility animal study","volume":"18","author":"Silva","year":"2016","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.xphs.2025.103974_bib0037","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbamem.2018.12.013","article-title":"Interaction of statins with phospholipid bilayers studied by solid-state NMR spectroscopy","volume":"1861","author":"Galiullina","year":"2019","journal-title":"Biochim Biophys Acta (BBA)-Biomembr"},{"key":"10.1016\/j.xphs.2025.103974_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112317","article-title":"pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment","volume":"144","author":"Nunes","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xphs.2025.103974_bib0039","doi-asserted-by":"crossref","first-page":"7373","DOI":"10.1016\/j.bmcl.2011.10.016","article-title":"Tumor bombesin analog loaded long-circulating and pH-sensitive liposomes as tool for tumor identification","volume":"21","author":"de Barros","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.xphs.2025.103974_bib0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1166\/jbn.2015.1910","article-title":"Bombesin encapsulated in long-circulating pH-sensitive liposomes as a radiotracer for breast tumor identification","volume":"11","author":"De Barros","year":"2015","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.xphs.2025.103974_bib0041","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.3390\/molecules25235649","article-title":"pH-sensitive biomaterials for drug delivery","volume":"25","author":"Zhuo","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.xphs.2025.103974_bib0042","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"2","author":"Bozzuto","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2025.103974_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/srep38267","article-title":"Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species","volume":"6","author":"Liang","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.xphs.2025.103974_bib0044","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.xphs.2025.103974_bib0045","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.2147\/IJN.S194304","article-title":"Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer","volume":"14","author":"Wang","year":"2019","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/2211-5463.13330","article-title":"Doxorubicin promotes breast cancer cell migration and invasion via DCAF13","volume":"12","author":"Sun","year":"2022","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.xphs.2025.103974_bib0047","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-021-01452-5","article-title":"Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases","volume":"23","author":"Mohammed","year":"2021","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.xphs.2025.103974_bib0048","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2018.11.003","article-title":"NF-kappaB signaling and integrin-beta1 inhibition attenuates osteosarcoma metastasis via increased cell apoptosis","volume":"123","author":"Li","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.xphs.2025.103974_bib0049","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/CAD.0b013e3282ef4571","article-title":"Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells","volume":"18","author":"Bar-On","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.xphs.2025.103974_bib0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2021.05.040","article-title":"Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy","volume":"335","author":"Li","year":"2021","journal-title":"J Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:27:17Z","timestamp":1766525237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022354925004289"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103974","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-encapsulated with shikonin\/doxorubicin pH-sensitive liposomes: Preparation, characterization and its synergistic effect in drug-resistant breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"103974"}}